1. Recurrent Ta Low-grade Non-muscle-invasive Bladder Cancer: What Are the Options? 
Morgan Rouprêt, Per-Uno Malmstrom, Peter Black 
European Urology Oncology 
DOI: /j.euo
Copyright © 2019 The Authors Terms and Conditions

2. Fig. 1
Risk of recurrence or progression of Ta low-grade NMIBC. EORTC=European Organisation for Research and Treatment of Cancer; NMIBC=non-muscle-invasive bladder cancer.
Adapted from Sylvester et al. [1].
European Urology Oncology DOI: ( /j.euo )
Copyright © 2019 The Authors Terms and Conditions

3. Fig. 2
Multiphase, multiarm trial designs. BCG=bacillus Calmette-Guérin; EBRT=external beam radiotherapy; NMIBC=non-muscle-invasive bladder cancer; RP2D=recommended phase 2 dose.
Adapted from Hahn [18].
European Urology Oncology DOI: ( /j.euo )
Copyright © 2019 The Authors Terms and Conditions